InsidersTradesSigma
Total declarations
Company
▲ Purchases (15 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
15
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-21.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Encrantz Staffan, Director. Insider active across 1 company, notably Sight Sciences, Inc.. Aggregated, 22 reports have been recorded. Breakdown: 15 buys · 1 sell. Total volume traded: €15.2m. History available since 19 July 2021. The latest transaction was disclosed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Encrantz Staffan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
14,100 sharesCommon StockSEC:0001193125-26-267752:0
Canonical exit: 8 Sept 2026 (T+90)
28,261 shares0Common StockSEC:0001193125-26-259570:0
13,958 shares@ US$8.3080.7% of flowCommon StockSEC:0001193125-25-325277:0
Canonical exit: 16 Mar 2026 (T+90)
21,674 shares@ US$4.1720.5% of flowCommon StockSEC:0000950170-25-083413:0
Canonical exit: 2 Sept 2025 (T+90)
42,753 shares@ US$3.670.9% of flowCommon StockSEC:0000950170-25-081367:0
Canonical exit: 28 Aug 2025 (T+90)
41,346 shares@ US$3.4360.8% of flowCommon StockSEC:0000950170-25-079292:0
Canonical exit: 25 Aug 2025 (T+90)
26,715 shares@ US$3.5160.5% of flowCommon StockSEC:0000950170-25-079292:1
Canonical exit: 26 Aug 2025 (T+90)
60,128 shares@ US$3.5881.2% of flowCommon StockSEC:0000950170-25-079292:2
Canonical exit: 27 Aug 2025 (T+90)
120,000 shares@ US$2.531.0% of flowCommon StockSEC:0000950170-25-039010:0
551,802 shares@ US$3.737.2% of flowCommon StockSEC:0000950170-24-129885:0
17,366 shares0Common StockSEC:0000950170-24-071516:0
3,223 shares@ US$3.500.0% of flowCommon StockSEC:0000950170-23-067435:0
Canonical exit: 27 Feb 2024 (T+90)
21,855 shares@ US$3.08520.2% of flowCommon StockSEC:0000950170-23-066532:0
Canonical exit: 22 Feb 2024 (T+90)
79,234 shares@ US$2.24890.6% of flowCommon StockSEC:0000950170-23-065919:0
Canonical exit: 18 Feb 2024 (T+90)
339 shares@ US$2.000.0% of flowCommon StockSEC:0000950170-23-065273:0
Canonical exit: 14 Feb 2024 (T+90)
3,462 shares@ US$1.9970.0% of flowCommon StockSEC:0000950170-23-064582:0
Canonical exit: 12 Feb 2024 (T+90)
11,940 shares0Common StockSEC:0000950170-23-064579:0
11,940 shares0Common StockSEC:0000899243-23-015385:0
1,802 shares@ US$7.98110.1% of flowCommon StockSEC:0000899243-22-018500:0
Canonical exit: 11 Aug 2022 (T+90)
84,254 shares@ US$18.849.1% of flowCommon StockSEC:0000899243-21-046456:0
Canonical exit: 27 Feb 2022 (T+90)
527,048 shares@ US$24.0070.3% of flowCommon StockSEC:0000899243-21-040878:0
Canonical exit: 16 Jan 2022 (T+90)
2,970,070 shares0Common StockSEC:0000899243-21-028879:0
22 of 22 declarations
About Encrantz Staffan
Encrantz Staffan is Administrateur of Sight Sciences, Inc. (XNAS, Director). He has 22 filings in total, and across the recent filings covered here, buys amount to EUR 13267634 and sells to EUR 1951626, with filings dating from 2021-07-19 to 2026-06-11.
